Insights

Analysis and perspectives on the global economy and markets from across Goldman Sachs
hero-card-grid
Goldman Sachs Exchanges
How a popular trade collapsed — and why it matters
Podcast|
Aug 13, 2024
The Latest
hero-card-grid
00:57
Markets
The case for Japanese stocks
Video|
Aug 19, 2024
hero-card-grid
Energy
Only a quarter of Saudi Arabia's $1 trillion capex plan will go into oil
Aug 14, 2024
hero-card-grid
Goldman Sachs Exchanges
Women in the workforce: Analyzing the gains and gaps
Podcast|
Aug 20, 2024
Goldman Sachs TalksConversations with pioneering business and cultural leaders about leadership, strategy, and how business and the economy are changing.
See All Goldman Sachs Talks
In Focus: Artificial Intelligence
Featured Report
Weighing the GLP-1 market
The newest generation of GLP-1 drugs are being hailed by some as “miracle drugs” for the treatment of obesity. But GLP-1s are expensive, insurance coverage is limited, and not everyone with obesity can or wants to take them. Just how large the addressable market for GLP-1s actually is, and what that means for the drug companies developing them, other exposed industries, and the wider economy, is Top of Mind.
All Insights